Approval · Notice of Compliance 21757 · 2019
APRESOLINE: Notice of Compliance 21757
Issued January 17, 2019
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 21757
- Date
- January 17, 2019
- Company
- Sterimax Inc.Oakville, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Addition of a new drug product manufacturing site
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| APRESOLINE | Not yet assigned | — |
Medicinal ingredients
- HYDRALAZINE HCL 20 MG per ML